ARTICLE | Clinical News
CCD 1042: Filed two INDs to begin Phase I trials
December 6, 1993 8:00 AM UTC
CoCensys Inc. (COCN) Product: CCD 1042 small molecule anticonvulsant that enhances the activity of the GABA (gamma-aminobutyric acid) neurotransmitter Indication: Petit mal epiliepsy (absence seizures...